Scientific Sessions 2025  /  Inflammation, Pollution, Microplastics and CAD  /  Canakinumab - can it find a role for CAD?
Logo

American Heart Association

  87
  0

Final ID:

Canakinumab - can it find a role for CAD?

  • Ridker, Paul  ( BRIGHAM WOMENS HOSPITAL , Boston , Massachusetts , United States )
    • Author Disclosures:
    Paul Ridker: DO have relevant financial relationships ; Research Funding (PI or named investigator):Kowa, Novartis, Pfizer, NovoNordisk:Active (exists now) ; Advisor:Uppton, Bitteroot Bio, Angiowave, Peter Munk University of Toronto, Leducq Foundation:Active (exists now) ; Consultant:Novartis, Novo Nordisk, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSK Behring, Civi Biopharm, GSK, Eil Lilly, New Amsterdam, CardioTherapeutics, Caristo, Tourmaline Bio:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation, Pollution, Microplastics and CAD

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Inflammation 101 – what the clinician needs to know about inflammation and CAD

Giannarelli Chiara, Moore Kathryn, Swirski Filip

So I've got bits of plastic in my arteries?

Paolisso Giuseppe, Marfella Raffaele

More abstracts from these authors:
Emerging Therapies in AMI: Targeting Inflammation and Microvascular Obstruction

Ridker Paul

Beyond Lipids: The Current and Future Landscape of Anti-Inflammatory Therapies for ASCVD

Ridker Paul, Ballantyne Christie

You have to be authorized to contact abstract author. Please, Login
Not Available